Whitby’s Thermo Fisher Scientific plant ready to begin supplying Molnupiravir upon approval, Merck says

Merck Canada president and managing director Marwan Akar said Monday that the Thermo Fisher Scientific plant in Whitby, Ont., will be ready to begin manufacturing and supplying Molnupiravir, Merck’s COVID-19 antiviral treatment, soon after receiving approval from Health Canada.